Form 4: Ginkgo Bioworks CFO Sells Shares for Tax Withholding

Ginkgo Bioworks Holdings, Inc. CFO Steven P. Coen sold shares to cover tax obligations related to vested performance-based restricted stock units.

Summary

• Steven P. Coen, Chief Financial Officer of Ginkgo Bioworks Holdings, Inc., reported transactions involving Class A Common Stock on April 10, 2026, and April 13, 2026.
• On April 10, 2026, 28,368 shares were acquired and disposed of, and 45,553 shares were acquired and disposed of, related to performance-based restricted stock units (PSUs).
• These transactions were part of a 'sell to cover' strategy to satisfy tax withholding obligations upon the vesting of PSUs.
• On April 13, 2026, an additional 33,171 shares were disposed of at a price of $6.414 per share.
• The PSUs vested based on performance metrics related to finance team cash flow reduction targets (62% achievement) and company-wide cash flow reduction targets (67% achievement) for the year 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. While it involves significant share disposals by the CFO, these are explicitly for tax withholding related to vested performance awards, not discretionary trading, and are a standard practice.

Positives

• Vesting of performance-based restricted stock units indicates achievement of company and team financial targets.
• The 'sell to cover' transactions are standard procedures for managing tax liabilities associated with equity compensation and do not represent discretionary trading.

Negatives

• A total of 61,539 shares (28,368 + 33,171) were disposed of by the CFO on April 10th and 13th, 2026, reducing direct beneficial ownership.
• The sale of 33,171 shares on April 13, 2026, at $6.414 per share, represents a cash-out event for the CFO.

Risks

• The performance metrics for the PSUs were based on cash flow reduction targets, suggesting a focus on cost management which could imply revenue or growth challenges.
• The need for 'sell to cover' transactions, while standard, indicates that the executive may not have sufficient cash on hand to cover tax liabilities without selling company stock.

Future Outlook

The filing does not contain forward-looking statements or guidance. It reports on past transactions related to equity compensation vesting and tax obligations.

Management Comments

• Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person.
• The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a 'sell to cover' transaction.

Industry Context

StockSavvy.ai notes that insider sales for tax withholding are common, especially with performance-based equity awards. The specific performance metrics (cash flow reduction) suggest a company focus on operational efficiency and cost control, which is a prevalent theme across many growth-oriented biotech and synthetic biology companies navigating market conditions.

Stakeholder Impact

• Shareholders: The sale of shares by the CFO, even for tax purposes, reduces the direct ownership stake of a key executive. However, the 'sell to cover' nature mitigates concerns about a lack of confidence in the company's future.
• Employees: The vesting of PSUs and subsequent tax settlement for the CFO may reflect broader compensation structures and performance achievements within the company.
• Management: The transactions highlight the financial implications of executive compensation plans and the need for careful tax planning.

Key Dates

Recommendation

The filing reports routine insider transactions for tax withholding purposes related to vested performance awards. There is no indication of a change in the CFO's fundamental view of the company's prospects, nor does it reveal new material information about the company's operations or financial health that would warrant a buy or sell recommendation.

Keywords

Ginkgo Bioworks, DNA, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, PSUs, Tax Withholding, CFO, Steven P. Coen, Beneficial Ownership, SEC Filing